Glandular orientation and shape determined by computational pathology could identify aggressive tumor for early colon carcinoma: a triple-center study

[1]  Cheng Lu,et al.  Nuclear shape, architecture and orientation features from H&E images are able to predict recurrence in node-negative gastric adenocarcinoma , 2019, Journal of Translational Medicine.

[2]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[3]  A. Madabhushi,et al.  Nuclear shape and orientation features from H&E images predict survival in early-stage estrogen receptor-positive breast cancers , 2018, Laboratory Investigation.

[4]  F. Marincola,et al.  International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study , 2018, The Lancet.

[5]  Rajarsi R. Gupta,et al.  Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images. , 2018, Cell reports.

[6]  Andrew Janowczyk,et al.  Combination of nuclear NF-κB/p65 localization and gland morphological features from surgical specimens is predictive of early biochemical recurrence in prostate cancer patients , 2018, Medical Imaging.

[7]  David B. A. Epstein,et al.  Glandular Morphometrics for Objective Grading of Colorectal Adenocarcinoma Histology Images , 2017, Scientific Reports.

[8]  A. Madabhushi,et al.  Prediction of recurrence in early stage non-small cell lung cancer using computer extracted nuclear features from digital H&E images , 2017, Scientific Reports.

[9]  A. Madabhushi,et al.  An oral cavity squamous cell carcinoma quantitative histomorphometric-based image classifier of nuclear morphology can risk stratify patients for disease-specific survival , 2017, Modern Pathology.

[10]  Kazuaki Matsumura,et al.  Inhibition of protein aggregation by zwitterionic polymer-based core-shell nanogels , 2017, Scientific Reports.

[11]  Junzhou Huang,et al.  Comprehensive Computational Pathological Image Analysis Predicts Lung Cancer Prognosis , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[12]  G. Pazour,et al.  Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness , 2017, Scientific Reports.

[13]  Ce Zhang,et al.  Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features , 2016, Nature Communications.

[14]  Adrien Depeursinge,et al.  Automated classification of brain tumor type in whole-slide digital pathology images using local representative tiles , 2016, Medical Image Anal..

[15]  S. Edge,et al.  Effect of Incorporation of Pretreatment Serum Carcinoembryonic Antigen Levels Into AJCC Staging for Colon Cancer on 5-Year Survival. , 2015, JAMA surgery.

[16]  Christophe Chefd'Hotel,et al.  Automatic glandular and tubule region segmentation in histological grading of breast cancer , 2015, Medical Imaging.

[17]  V. Moreno,et al.  Genomic classifier ColoPrint predicts recurrence in stage II colorectal cancer patients more accurately than clinical factors. , 2015, The oncologist.

[18]  G. Goel.  Evolving Role of Gene Expression Signatures as Biomarkers in Early-Stage Colon Cancer , 2014, Journal of Gastrointestinal Cancer.

[19]  T. Rebbeck,et al.  Co-Occurring Gland Angularity in Localized Subgraphs: Predicting Biochemical Recurrence in Intermediate-Risk Prostate Cancer Patients , 2014, PloS one.

[20]  Anant Madabhushi,et al.  A Quantitative Histomorphometric Classifier (QuHbIC) Identifies Aggressive Versus Indolent p16-Positive Oropharyngeal Squamous Cell Carcinoma , 2014, The American journal of surgical pathology.

[21]  A. Glas,et al.  Independent Validation of a Prognostic Genomic Signature (ColoPrint) for Patients With Stage II Colon Cancer , 2013, Annals of surgery.

[22]  Anant Madabhushi,et al.  Cell cluster graph for prediction of biochemical recurrence in prostate cancer patients from tissue microarrays , 2013, Medical Imaging.

[23]  Anindya Sarkar,et al.  Structure and Context in Prostatic Gland Segmentation and Classification , 2012, MICCAI.

[24]  Hanlin L. Wang,et al.  Colorectal carcinoma: Pathologic aspects. , 2012, Journal of gastrointestinal oncology.

[25]  R. Gelber,et al.  Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[26]  Mahmoud M. Kamel,et al.  The prognostic value of c‐Kit, K‐ras codon 12, and p53 codon 72 mutations in Egyptian patients with stage II colorectal cancer , 2010, Cancer.

[27]  S. Paik,et al.  Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorin. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  Purang Abolmaesumi,et al.  High-throughput detection of prostate cancer in histological sections using probabilistic pairwise Markov models , 2010, Medical Image Anal..

[29]  S. Eschrich,et al.  Gene expression profiles as predictors of poor outcomes in stage II colorectal cancer: A systematic review and meta-analysis. , 2009, Clinical colorectal cancer.

[30]  N. Wright,et al.  Colonic crypt organization and tumorigenesis , 2008, Nature Reviews Cancer.

[31]  Anant Madabhushi,et al.  Automated gland and nuclei segmentation for grading of prostate and breast cancer histopathology , 2008, 2008 5th IEEE International Symposium on Biomedical Imaging: From Nano to Macro.

[32]  M. Gonen,et al.  Identification of Patients with High-Risk Stage II Colon Cancer for Adjuvant Therapy , 2008, Diseases of the colon and rectum.

[33]  J. Lynch,et al.  Systemic and targeted therapy for advanced colon cancer , 2008, Expert review of gastroenterology & hepatology.

[34]  R. A. Zoroofi,et al.  An image analysis approach for automatic malignancy determination of prostate pathological images , 2007, Cytometry. Part B, Clinical cytometry.

[35]  S. Naik,et al.  A quantitative exploration of efficacy of gland morphology in prostate cancer grading , 2007, 2007 IEEE 33rd Annual Northeast Bioengineering Conference.

[36]  S. Dudoit,et al.  Stage II colon cancer prognosis prediction by tumor gene expression profiling. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  T. Vahlberg,et al.  Increased proliferation activity measured by immunoreactive Ki67 is associated with survival improvement in rectal/recto sigmoid cancer. , 2005, World journal of gastroenterology.

[38]  I. Yang,et al.  Molecular staging for survival prediction of colorectal cancer patients. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  C. Ko,et al.  Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. , 2005, Journal of the National Cancer Institute.

[40]  E. Sabo,et al.  Epidermal Growth Factor Receptor, c-MET, β-Catenin, and p53 Expression as Prognostic Indicators in Stage II Colon Cancer , 2004, Clinical Cancer Research.

[41]  Fuhui Long,et al.  Feature selection based on mutual information criteria of max-dependency, max-relevance, and min-redundancy , 2003, IEEE Transactions on Pattern Analysis and Machine Intelligence.

[42]  G. Miller,et al.  Errors in histological grading by prostatic needle biopsy specimens: frequency and predisposing factors , 2000, The Journal of pathology.

[43]  M E Hammond,et al.  Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. , 2000, Archives of pathology & laboratory medicine.

[44]  C. Ratto,et al.  Prognostic factors in colorectal cancer , 1998, Diseases of the colon and rectum.

[45]  C. Andrews,et al.  The effect of transfection of the CEA gene on the metastatic behavior of the human colorectal cancer cell line MIP-101. , 1995, Cancer letters.

[46]  R. Newcombe,et al.  Observer variation in histopathological diagnosis and grading of cervical intraepithelial neoplasia. , 1989, BMJ.

[47]  L. V. van't Veer,et al.  Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  K. Shirouzu,et al.  Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study. , 2007, Surgery.

[49]  E. Sabo,et al.  Epidermal growth factor receptor, c-MET, beta-catenin, and p53 expression as prognostic indicators in stage II colon cancer: a tissue microarray study. , 2004, Clinical cancer research : an official journal of the American Association for Cancer Research.

[50]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..